New Diabetic Retinopathy Treatment Gets FDA “Breakthrough Therapy” Approval
News, Type 2 Diabetes News
The U.S. Food and Drug Administration on Wednesday, March 25 expanded the approved use for Eylea (aflibercept) injections for treatment of diabetic retinopathy in patients with diabetic macular edema. According ... Read more